Position in LUNG
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,624,819
+$27,883 QoQ
Shares Held
2,788,323
0.0% QoQ
Ownership
6.49%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#3
of 108 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LUNG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $637,521,571 across 15 Medical Devices names. LUNG ranks #13 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,049,000 | $159,710,250 | |
| 2 | NVCR |
NovoCure Ltd
|
9,913,401 | $150,188,025 | |
| 3 | INSP |
Inspire Medical Systems, Inc.
|
1,931,436 | $86,161,359 | |
| 4 | BBNX |
Beta Bionics, Inc.
|
4,393,714 | $68,849,498 | |
| 5 | NPCE |
NeuroPace Inc
|
2,911,122 | $46,257,728 | |
| 6 | GMED |
Globus Medical Inc
|
468,922 | $37,049,527 | |
| 7 | PRCT |
PROCEPT BioRobotics Corp
|
1,003,000 | $22,647,740 | |
| 8 | LIVN |
LivaNova PLC
|
254,957 | $20,965,114 |
All Filings in LUNG
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,624,819 | 2,788,323 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,596,936 | 2,788,323 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,504,693 | 2,038,323 | Shares | Sole | 2026-02-12 | |
| 2023-06-30 | $537,510 | 41,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $793,780 | 71,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $598,530 | 71,000 | Shares | Sole | 2023-02-14 | |
| 2021-09-30 | $3,152,279 | 87,612 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,761,230 | 85,250 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||